RPS mandates are similarly embedded in markets and networks in both cases with similar effects on RE production, but Minnesota’s more traditional approach gives regulators greater authority over the type and location of RE production compared to Connecticut’s more market-driven approach. Our analysis suggests that policy analysts should pay closer attention to the institutional environments in which policy instruments are embedded, and we offer several testable propositions about how mandate, market, and network interactions likely shape RE production.

Disparities in access to medication-assisted treatment are a major problem. This study estimated and compared drive time to the nearest opioid treatment program (OTP) and office-based buprenorphine treatment (OBBT) across the urban-rural continuum in the U.S.

Drive time was calculated between the longitude and latitude of population weighted block group centroids and the longitude and latitude of the nearest OTP and OBBT. Rural-Urban Commuting Area (RUCA) codes were used for defining rurality. The Integrated Nested Laplace Approximation approach was used for statistical analysis.

The mean travel time to the nearest OBBT compared to OTP decreased by 7.18 min (95 % CI = 7.23-7.14) in metropolitan cores, 36.63 min (95 % CI = 37.12-36.15) in micropolitan cores, 38.84 min (95 % CI = 39.57-38.10) in small town cores, and 40.16 min (95 % CI = 40.81-39.50) in rural areas. Additionally, travel burden to the nearest OTP would be more than 60 min for 13,526,605 people and more than 90 min for 5,371,852 people. The travel burden to the nearest OBBT would be more than 60 min for 845,991 people and more than 90 min for 149,297 people.

The mean drive time to the closest OBBT was significantly smaller than the mean drive time to the closest OTP. Analysis of barriers to access is necessary to devising creative initiatives to improve access to critical opioid use disorder treatment services.

The mean drive time to the closest OBBT was significantly smaller than the mean drive time to the closest OTP. Analysis of barriers to access is necessary to devising creative initiatives to improve access to critical opioid use disorder treatment services.This work reports for the first time the UVC photodegradation of cilastatin, a renal dehydropeptidase inhibitor co-adminstered with the imipenem antibiotic. Initially, solutions of cilastatin at varying concentrations were prepared in ultra-pure water and the direct photolysis of cilastatin was monitored under 254-nm irradiation. Degradation was slower at higher initial cilastatin concentrations, due to absorption saturation. Of the different eluting photoproducts, only one was tentatively identified as oxidized cilastatin bearing a sulfoxide group. UV-254 photolysis occurred faster at lower pH values, because the protonated forms of the molecule (H3A+, H2A) have both higher absorption coefficients and higher photolysis quantum yields than the non-protonated ones (HA-, A2-). see more The direct photolysis of cilastatin does not involve •OH, as excluded by experiments in which t-butanol was added as •OH scavenger, whereas the presence of humic acids inhibited photolysis due to competition for radiation absorption. The same explanation partially accounts for the observation that the photolysis kinetics of cilastatin was slower in tap water, river water and treated wastewater samples compared to ultra-pure water. Moreover, the direct photolysis quantum yield was also lower in water matrices compared to ultra-pure water. Similar findings reported for triclosan and the herbicide 2-methyl-4-chlorophenoxyacetic acid in previous studies might suggest that the water matrix components could carry out either physical quenching of cilastatin’s excited states or back-reduction to cilastatin of the partially oxidized degradation intermediates. Overall, the present results demonstrate that UVC irradiation is a fast and efficient process for the degradation of cilastatin in natural water and treated wastewater.Integration of semiconducting nanostructures with noble metal nanoparticles are turning highly desirable for cost efficient energy and environmental related applications. From this viewpoint, we report on a facile aqueous synthesis of polymer capped gold (Au) nanoparticles on free standing 2D layered structures of zinc oxide (ZnO) to result with ZnO/Au nanocomposites. Concentration of Au nanoparticles were observed to promote the preferential growth of ZnO along the (002) wurtzite plane. The ZnO/Au structures and their morphological dissemination was noted to be of few. This flake like structure was also noted to be greatly influenced by the concentration of Au in the colloidal blend. Optical band edge transformations noted in the absorption spectra across the lower wavelength region and the shift in surface plasmon resonance (SPR) towards the red region of the visible spectrum signify the improved absorptivity of the heterostructures along the visible spectrum. These heterostructures exhibited remarkable visible light driven photocatalytic activity (99% efficiency) on par with pristine ZnO. The findings also attest this new class of composite structures to open up new openings in diversified solar energy conversion related functions.Non-steroidal anti-inflammatory drugs (NSAIDs) are medications used individually or as mixtures with other pharmaceuticals for the treatment of various illnesses. Their easy accessibility and high human consumption have resulted to their detection at high concentrations in South African water resources. In the present work, an extensive review of the occurrence and ecotoxicological risk assessment of NSAIDs in South African aquatic environment is provided. Reviewed literature suggested ibuprofen, naproxen, diclofenac, ketoprofen and fenoprofen as the most prominent NSAIDs in the South African aquatic environment. Among these NSAIDs, higher concentrations of ibuprofen are common in South African waters. As a result, this drug was found to pose high ecotoxicological risks towards the aquatic organisms with the highest risk quotients of 14.9 and 11.9 found for algae in surface water and wastewater, respectively. Like in other parts of the world, NSAIDs are not completely removed in wastewater treatment plants. Removal efficiencies below 0% due to higher concentrations of NSAIDs in wastewater effluents rather than influents were observed in certain instances.